中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 1
Jan.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(1): 215-219

Current status of research on nutritional support in end-stage liver disease

DOI: 10.3969/j.issn.1001-5256.2022.01.038

  • Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China

  • Received Date: 2021-05-05
  • Accepted Date: 2021-06-22
  • Published Date: 2022-01-20
    Abstract
  • There is a high prevalence rate of malnutrition in patients with end-stage liver disease, which often promotes disease progression and has a negative impact on the prognosis of patients. This article briefly describes the etiology of malnutrition in end-stage liver disease and introduces the research advances in nutrition screening, evaluation, and treatment in end-stage liver disease in China and globally, hoping to provide inspiration for nutritional support in patients with end-stage liver disease in China.

     

    • FullText(HTML)
  • loading
    • References(43)
  • [1]
    BUNCHORNTAVAKUL C, REDDY KR. Review article: Malnutrition/sarcopenia and frailty in patients with cirrhosis[J]. Aliment Pharmacol Ther, 2020, 51(1): 64-77. DOI: 10.1111/apt.15571.
    [2]
    NISHIKAWA H, ENOMOTO H, NISHIGUCHI S, et al. Sarcopenic obesity in liver cirrhosis: Possible mechanism and clinical impact[J]. Int J Mol Sci, 2021, 22(4): 1917. DOI: 10.3390/ijms22041917.
    [3]
    CHAPMAN B, SINCLAIR M, GOW PJ, et al. Malnutrition in cirrhosis: More food for thought[J]. World J Hepatol, 2020, 12(11): 883-896. DOI: 10.4254/wjh.v12.i11.883.
    [4]
    GRVNGREIFF K, REINHOLD D, WEDEMEYER H. The role of zinc in liver cirrhosis[J]. Ann Hepatol, 2016, 15(1): 7-16. DOI: 10.5604/16652681.1184191.
    [5]
    KHAN MA, DAR HA, BABA MA, et al. Impact of vitamin d status in chronic liver disease[J]. J Clin Exp Hepatol, 2019, 9(5): 574-580. DOI: 10.1016/j.jceh.2019.03.001.
    [6]
    LEE WG, WELLS CI, MCCALL JL, et al. Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis[J]. Diabetes Metab Res Rev, 2019, 35(6): e3157. DOI: 10.1002/dmrr.3157.
    [7]
    MVLLER MJ, LAUTZ HU, PLOGMANN B, et al. Energy expenditure and substrate oxidation in patients with cirrhosis: The impact of cause, clinical staging and nutritional state[J]. Hepatology, 1992, 15(5): 782-794. DOI: 10.1002/hep.1840150507.
    [8]
    European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease[J]. J Hepatol, 2019, 70(1): 172-193. DOI: 10.1016/j.jhep.2018.06.024.
    [9]
    Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Gastroenterology, Chinese Medical Association. Clinical guidelines on nutrition in end-stage liver disease[J]. J Clin Hepatol, 2019, 35(6): 1222-1230. DOI: 10.3969/j.issn.1001-5256.2019.06.010.

    中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 临床肝胆病杂志, 2019, 35(6): 1222-1230. DOI: 10.3969/j.issn.1001-5256.2019.06.010.
    [10]
    BORHOFEN SM, GERNER C, LEHMANN J, et al. The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis[J]. Dig Dis Sci, 2016, 61(6): 1735-1743. DOI: 10.1007/s10620-015-4015-z.
    [11]
    GEORGIOU A, PAPATHEODORIDIS GV, ALEXOPOULOU A, et al. Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: The KIRRHOS study[J]. Br J Nutr, 2019, 122(12): 1368-1376. DOI: 10.1017/S0007114519002277.
    [12]
    BOULHOSA R, LOURENÇO RP, CÖRTES DM, et al. Comparison between criteria for diagnosing malnutrition in patients with advanced chronic liver disease: GLIM group proposal versus different nutritional screening tools[J]. J Hum Nutr Diet, 2020, 33(6): 862-868. DOI: 10.1111/jhn.12759.
    [13]
    WU Y, ZHU Y, FENG Y, et al. Royal free hospital-nutritional prioritizing tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002[J]. Br J Nutr, 2020, 124(12): 1293-1302. DOI: 10.1017/S0007114520002366.
    [14]
    XIAO HJ, YE Q, QI YM, et al. Comparison of RFH-NPT and NRS2002 for nutritional risk screening in liver cirrhosis inpatients[J]. Acta Nutrimenta Sinica, 2019, 41(3): 257-260, 264. DOI: 10.3969/j.issn.0512-7955.2019.03.011.

    肖慧娟, 叶青, 齐玉梅, 等. RFH-NPT与NRS2002在肝硬化住院患者营养风险筛查中的比较研究[J]. 营养学报, 2019, 41(3): 257-260, 264. DOI: 10.3969/j.issn.0512-7955.2019.03.011.
    [15]
    TIAN YD, ZHANG Y, LI R, et al. Value of different nutritional screening tools on evaluating nutritional status of patients with liver disease[J/CD]. Chin J Liver Dis(Electronic Edition), 2019, 11(3): 52-57. DOI: 10.3969/j.issn.1674-7380.2019.03.010.

    田银娣, 张媛, 李茹, 等. 不同营养筛查工具评估肝病患者营养状况的价值[J/CD]. 中国肝脏病杂志(电子版), 2019, 11(3): 52-57. DOI: 10.3969/j.issn.1674-7380.2019.03.010.
    [16]
    BOOI AN, MENENDEZ J, NORTON HJ, et al. Validation of a screening tool to identify undernutrition in ambulatory patients with liver cirrhosis[J]. Nutr Clin Pract, 2015, 30(5): 683-689. DOI: 10.1177/0884533615587537.
    [17]
    MCFARLANE M, HAMMOND C, ROPER T, et al. Comparing assessment tools for detecting undernutrition in patients with liver cirrhosis[J]. Clin Nutr ESPEN, 2018, 23: 156-161. DOI: 10.1016/j.clnesp.2017.10.009.
    [18]
    SHI SY, HAN JJ, YAN M, et al. Nutritional risk assessment in patients with chronic liver disease[J]. Chin J Hepatol, 2014, 22(7): 536-539. DOI: 10.3760/cma.j.issn.1007-3418.2014.07.012.

    时淑云, 韩军军, 闫茗, 等. 慢性肝病患者的营养风险评估[J]. 中华肝脏病杂志, 2014, 22(7): 536-539. DOI: 10.3760/cma.j.issn.1007-3418.2014.07.012.
    [19]
    TRAUB J, BERGHEIM I, HORVATH A, et al. Validation of malnutrition screening tools in liver cirrhosis[J]. Nutrients, 2020, 12(5): 1306. DOI: 10.3390/nu12051306.
    [20]
    LIMA E, ALMEIDA BL, GOMES HB, et al. Agreement between Graz Malnutrition Screening (GMS) with subjective nutritional assessment instruments in hospitalized patients[J]. Nutr Hosp, 2018, 35(5): 1138-1144. DOI: 10.20960/nh.1853.
    [21]
    CASAS DEZA D, BETORÉ GLARIA ME, SANZ-PARÍS A, et al. Mini nutritional assessment - short form is a useful malnutrition screening tool in patients with liver cirrhosis, using the global leadership initiative for malnutrition criteria as the gold standard[J]. Nutr Clin Pract, 2021, 36(5): 1003-1010. DOI: 10.1002/ncp.10640.
    [22]
    MARR KJ, SHAHEEN AA, LAM L, et al. Nutritional status and the performance of multiple bedside tools for nutrition assessment among patients waiting for liver transplantation: A Canadian experience[J]. Clin Nutr ESPEN, 2017, 17: 68-74. DOI: 10.1016/j.clnesp.2016.10.003.
    [23]
    NUNES G, SANTOS CA, BAROSA R, et al. Outcome and nutritional assessment of chronic liver disease patients using anthropometry and subjective global assessment[J]. Arq Gastroenterol, 2017, 54(3): 225-231. DOI: 10.1590/S0004-2803.201700000-28.
    [24]
    KAPPUS MR, WEGERMANN K, BOZDOGAN E, et al. Use of skeletal muscle index as a predictor of wait-list mortality in patients with end-stage liver disease[J]. Liver Transpl, 2020, 26(9): 1090-1099. DOI: 10.1002/lt.25802.
    [25]
    MORIWAKI EI, ENOMOTO H, SAITO M, et al. The anthropometric assessment with the bioimpedance method is associated with the prognosis of cirrhotic patients[J]. In Vivo, 2020, 34(2): 687-693. DOI: 10.21873/invivo.11825.
    [26]
    ESPIRITO SANTO SILVA DD, WAITZBERG DL, PASSOS DE JESUS R, et al. Phase angle as a marker for sarcopenia in cirrhosis[J]. Clin Nutr ESPEN, 2019, 32: 56-60. DOI: 10.1016/j.clnesp.2019.05.003.
    [27]
    RUIZ-MARGÁIN A, XIE JJ, ROMÁN-CALLEJA BM, et al. Phase angle from bioelectrical impedance for the assessment of sarcopenia in cirrhosis with or without ascites[J]. Clin Gastroenterol Hepatol, 2021, 19(9): 1941-1949. e2. DOI: 10.1016/j.cgh.2020.08.066.
    [28]
    CIOCÎRLAN M, CAZAN AR, BARBU M, et al. Subjective global assessment and handgrip strength as predictive factors in patients with liver cirrhosis[J]. Gastroenterol Res Pract, 2017, 2017: 8348390. DOI: 10.1155/2017/8348390.
    [29]
    MOCTEZUMA-VELAZQUEZ C, EBADI M, BHANJI RA, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis[J]. Clin Nutr, 2019, 38(6): 2696-2703. DOI: 10.1016/j.clnu.2018.11.024.
    [30]
    KALAFATELI M, MANTZOUKIS K, CHOI YAU Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score[J]. J Cachexia Sarcopenia Muscle, 2017, 8(1): 113-121. DOI: 10.1002/jcsm.12095.
    [31]
    HOU W, JIANG ZM, YANG J, et al. Consensus on the clinical nutritional intervention for patients with chronic liver diseases[J]. J Clin Hepatol, 2017, 33(7): 1236-1245. DOI: 10.3969/j.issn.1001-5256.2017.07.006.

    侯维, 蒋朱明, 杨剑, 等. 慢性肝病患者肠外肠内营养支持与膳食干预专家共识[J]. 临床肝胆病杂志, 2017, 33(7): 1236-1245. DOI: 10.3969/j.issn.1001-5256.2017.07.006.
    [32]
    PLAUTH M, BERNAL W, DASARATHY S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521. DOI: 10.1016/j.clnu.2018.12.022.
    [33]
    ZHU B, ZOU CC, ZHENG X. Malnutrition assessment and nutrition support therapy for end-stage liver disease[J]. J Clin Hepatol, 2017, 33(9): 1699-1706. DOI: 10.3969/j.issn.1001-5256.2017.09.014.

    朱彬, 邹聪聪, 郑昕. 终末期肝病的营养不良评价体系和营养支持治疗[J]. 临床肝胆病杂志, 2017, 33(9): 1699-1706. DOI: 10.3969/j.issn.1001-5256.2017.09.014.
    [34]
    CAMPION D, GIOVO I, PONZO P, et al. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis[J]. World J Hepatol, 2019, 11(6): 489-512. DOI: 10.4254/wjh.v11.i6.489.
    [35]
    LIU J, QIAO XY, SHI L, et al. Quality evaluation and comparative interpretation of guidelines on nutrition in liver disease from 2017 to 2019[J]. Chin J Evid-based Med, 2020, 20(9): 1083-1091. DOI: 10.7507/1672-2531.201907044.

    刘婧, 乔馨瑶, 石磊, 等. 2017~2019年肝病营养指南的质量评价及对比解读[J]. 中国循证医学杂志, 2020, 20(9): 1083-1091. DOI: 10.7507/1672-2531.201907044.
    [36]
    IQBAL U, JADEJA RN, KHARA HS, et al. A comprehensive review evaluating the impact of protein source (vegetarian vs. meat based) in hepatic encephalopathy[J]. Nutrients, 2021, 13(2): 370. DOI: 10.3390/nu13020370.
    [37]
    BUTTERWORTH RF. Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: A systematic review with meta-analysis[J]. Metab Brain Dis, 2020, 35(1): 75-81. DOI: 10.1007/s11011-019-00463-8.
    [38]
    BUTTERWORTH RF, MCPHAIL M. L-Ornithine L-Aspartate (LOLA) for hepatic encephalopathy in cirrhosis: Results of randomized controlled trials and meta-analyses[J]. Drugs, 2019, 79(Suppl 1): 31-37. DOI: 10.1007/s40265-018-1024-1.
    [39]
    KOOP AH, MOUSA OY, PHAM LE, et al. An argument for vitamin D, A, and zinc monitoring in cirrhosis[J]. Ann Hepatol, 2018, 17(6): 920-932. DOI: 10.5604/01.3001.0012.7192.
    [40]
    CHEN T, ZUO X, WANG S, et al. The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis[J]. Medicine (Baltimore), 2020, 99(19): e20296. DOI: 10.1097/MD.0000000000020296.
    [41]
    MOSZAK M, SZULIŃSKA M, WALCZAK-GAȽĘZEWSKA M, et al. Nutritional approach targeting gut microbiota in NAFLD-to date[J]. Int J Environ Res Public Health, 2021, 18(4). DOI: 10.3390/ijerph18041616.
    [42]
    CAO Q, YU CB, YANG SG, et al. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(1): 9-16. DOI: 10.1016/j.hbpd.2018.01.005.
    [43]
    DIETERICH W, SCHUPPAN D, SCHINK M, et al. Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity[J]. Clin Nutr, 2019, 38(2): 697-707. DOI: 10.1016/j.clnu.2018.03.017.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (548) PDF downloads(152) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return